Creation of Enantioselective Biocatalysts for Organic Chemistry by In Vitro Evolution

Angewandte Chemie (International Edition in English)

Volumn 36, Issue 24, 1997, Pages 2830-2832

  Reetz, Manfred T ^a   Zonta, Albin ^a   Schimossek, Klaus ^a   Liebeton, Klaus ^b   Jaeger, Karl Erich ^b  

^a MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Asymmetric catalysis; Enzyme catalysis; Lipases; Mutagenesis; Screening methods

Indexed keywords

EID: 0032491867     PISSN: 05700833     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.199728301     Document Type: Article

References (51)

1. See for example a) D. J. Berrisford, C. Bolm, K. B. Sharpless, Angew. Chem. 1995, 107, 1159-1171 ; Angew. Chem., Int. Ed. Engl. 1995, 34, 1059-1070; b) R. Noyori, Asymmetric Catalysis in Organic Synthesis, Wiley, New York, 1994; c) A. Pfaltz, Acc. Chem. Res. 1993, 26, 339-345.
2. See for example a) D. J. Berrisford, C. Bolm, K. B. Sharpless, Angew. Chem. 1995, 107, 1159-1171 ; Angew. Chem., Int. Ed. Engl. 1995, 34, 1059-1070; b) R. Noyori, Asymmetric Catalysis in Organic Synthesis, Wiley, New York, 1994; c) A. Pfaltz, Acc. Chem. Res. 1993, 26, 339-345.
3. See for example a) D. J. Berrisford, C. Bolm, K. B. Sharpless, Angew. Chem. 1995, 107, 1159-1171 ; Angew. Chem., Int. Ed. Engl. 1995, 34, 1059-1070; b) R. Noyori, Asymmetric Catalysis in Organic Synthesis, Wiley, New York, 1994; c) A. Pfaltz, Acc. Chem. Res. 1993, 26, 339-345.
4. See for example a) D. J. Berrisford, C. Bolm, K. B. Sharpless, Angew. Chem. 1995, 107, 1159-1171 ; Angew. Chem., Int. Ed. Engl. 1995, 34, 1059-1070; b) R. Noyori, Asymmetric Catalysis in Organic Synthesis, Wiley, New York, 1994; c) A. Pfaltz, Acc. Chem. Res. 1993, 26, 339-345.
5. a) Chirality in Industry: The Commercial Manufacture and Applications of Optically Active Compounds (Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, Chichester, 1992;
6. b) Chirality in Industry II: Developments in the Commercial Manufacture and Applications of Optically Active Compounds (Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, Chichester, 1997;
7. c) A. Persidis, Nat. Biotechnol. 1997, 15, 594-595;
8. d) R. A. Sheldon, Chirotechnology: Industrial Synthesis of Optically Active Compounds, Dekker, New York, 1993;
9. e) Industrial Enzymology (Eds.: T. Godfrey, S. West), 2nd ed., Macmillan Press, London, 1996.
10. a) H. G. Davies, R. H. Green, D. R. Kelly, S. M. Roberts, Biotransformations in Preparative Organic Chemistry: The Use of Isolated Enzymes and Whole Cell Systems in Synthesis. Academic Press, London, 1989;
11. b) C. H. Wong, G. M. Whitesides, Enzymes in Synthetic Organic Chemistry, Pergamon, Oxford, 1994;
12. c) Enzyme Catalysis in Organic Synthesis (Eds.: K. Drauz, H. Waldmann), VCH, Weinheim, 1995;
13. d) K. Faber, Biotransformations in Organic Chemistry. 3rd ed., Springer, Berlin, 1997.
14. a) A. J. Russell, A. R. Fersht, Nature (London) 1987, 328, 496-500;
15. b) M. Holmquist, I. G. Clausen, S. Patkar, A. Svendsen, K. Hult, J. Protein. Chem. 1995, 14, 217-224;
16. c) H. D. Beer, G. Wohlfahrt, J. E. G. McCarthy, D. Schomburg, R. D. Schmid, Protein Eng. 1996, 9, 507-517;
17. d) Y. Hirose, K. Kariya, Y. Nakanishi, Y. Kurono, K. Achiwa, Tetrahedron Lett. 1995, 36, 1063-1066;
18. e) M. J. Haas, R. D. Joerger, G. King, R. R. Klein, Ann. N. Y. Acad. Sci. 1996, 799, 115-128.
19. M. T. Reetz, A. Zonta, K. Schimossek, K. Liebeton, K.-E. Jaeger, patent application DEA 19731990.4.
20. a) K. Chen, F. H. Arnold, Proc. Natl. Acad. Sci. USA 1993, 90, 5618-5622;
21. b) W. P. C. Stemmer, Nature (London) 1994, 370, 389-391.
22. a) A. Crameri, G. Dawes, E. Rodriguez, Jr., S. Silver, W. P. C. Stemmer, Nat. Biotechnol. 1997, 15, 436-438;
23. b) W. P. C. Stemmer, Proc. Natl. Acad. Sci. USA 1994, 91, 10747-10751;
24. c) J.-H. Zhang, G. Dawes, W. P. C. Stemmer, Proc. Natl. Acad. Sci USA 1997, 94, 4504-4509.
25. a) J. C. Moore, F. H. Arnold, F. H. Nat. Biotechnol. 1996, 14, 458-467;
26. b) F. H. Arnold, Chem. Eng. Sci. 1996, 57, 5091-5102;
27. c) Z. Shao, F. H. Arnold, Curr. Opin. Struct. Biol. 1996, 6, 513-518;
28. d) L. You, F. H. Arnold, Protein. Eng. 1996, 9, 77-83;
29. e) A. Shinkai, A. Hirano, K. Aisaka, J. Biochem. (Tokyo) 1995, 120, 915-921.
30. a) K.-E. Jaeger, B. Schneidinger, K. Liebeton, D. Haas, M. T. Reetz, S. Philippou, G. Gerritse, S. Ransac, B. W. Dijkstra in Molecular Biology of Pseudomonads (Eds.: T. Nakazawa, K. Furukawa, D. Haas, S. Silver), ASM Press. Washington, 1996, pp. 319-330;
31. b) K.-E. Jaeger, K. Liebeton, A. Zonta, K. Schimossek, M. T. Reetz, Appl. Microbiol. Biotechnol. 1996, 46, 99-105.
32. a) D. W. Leung, E. Chen, D. V. Goeddel, Technique (Philadelphia) 1989, 1, 11-15;
33. b) K. A. Eckert, T. A. Kunkel, PCR Methods Appl. 1991, 1, 17-24;
34. c) R. C. Cadwell, G. F. Joyce, ibid 1992, 2, 28-33.
35. [6a,9] using the following primers: A: 5′-GCG CAA TTA ACC CTC ACT AAA GGG AAC AAA-3′ and B: 5′-GCG TAA TAC GAC TCA CTA TAG GGC GAA-3′ PCR was performed under the following conditions: 2 min at 98°C(1 × ): 1 min at 94°C,2 min at 64°C, 1 min at 72°C (25 ×); 7 min 72°C (1 × );
36. b) PCR products were ligated into plasmid pUCPL6A derived from pUCPKS (A. A. Watson, R. A. Alm, J. S. Mattick, Gene 1996, 172, 163-164). Plasmids were propagated in E. coli JM 109, isolated, and used to transform P. aeruginosa PABST7.1 ( K.-E. Jaeger, B. Schneidinger, F. Rosenau, M. Werner, D. Lang, B. W. Dijkstra, K. Schimossek, A. Zonta, M. T. Reetz, J. Mol. Catal. B: Enzym. 1997, 3, 3-12). For each new cycle of mutagenesis the lipase gene of the best perfoming clone for a given mutant generation was isolated and recloned into pBluescript II KS.
37. b) PCR products were ligated into plasmid pUCPL6A derived from pUCPKS (A. A. Watson, R. A. Alm, J. S. Mattick, Gene 1996, 172, 163-164). Plasmids were propagated in E. coli JM 109, isolated, and used to transform P. aeruginosa PABST7.1 ( K.-E. Jaeger, B. Schneidinger, F. Rosenau, M. Werner, D. Lang, B. W. Dijkstra, K. Schimossek, A. Zonta, M. T. Reetz, J. Mol. Catal. B: Enzym. 1997, 3, 3-12). For each new cycle of mutagenesis the lipase gene of the best perfoming clone for a given mutant generation was isolated and recloned into pBluescript II KS.
38. a) H. Flores, J. Osuna, J. Heitman, X. Soberon, Gene 1995, 157, 295-301;
39. b) M. S. Warren, S. J. Benkovic, Protein Eng. 1997, 10, 63-68.
40. Our current strategy of using the best mutant of a given generation is not necessarily optimal. It is conceivable that a less selective mutant may lead to a better result in the subsequent mutagenesis round.
41. a) W. Boland, C. Frössl, M. Lorenz, Synthesis 1991, 1049-1072;
42. b) F. Theil, Chem. Rev. 1995, 95, 2203-2227;
43. c) Lipases, Part A: Biotechnology (Eds.: B. Rubin, E. A. Dennis). Academic Press, San Diego, 1997 (Methods Enzymol. 1997, 284);
44. c) Lipases, Part A: Biotechnology (Eds.: B. Rubin, E. A. Dennis). Academic Press, San Diego, 1997 (Methods Enzymol. 1997, 284);
45. d) Lipases, Part B: Enzyme Characterization and Utilization (Eds.: B. Rubin, E. A. Dennis), Academic Press. San Diego, 1997 (Methods Enzymol. 1997, 286);
46. d) Lipases, Part B: Enzyme Characterization and Utilization (Eds.: B. Rubin, E. A. Dennis), Academic Press. San Diego, 1997 (Methods Enzymol. 1997, 286);
47. e) E. N. Vulfson in Lipases (Eds.: P. Woolley, S. B. Petersen), Cambridge University Press. Cambridge, 1994, pp. 271-288;
48. f) Engineering of/with Lipases (Ed.: F. X. Malcata), Kluwer, Dordrecht, 1996 (NATO ASI Ser. Ser. E. 1996, 317).
49. f) Engineering of/with Lipases (Ed.: F. X. Malcata), Kluwer, Dordrecht, 1996 (NATO ASI Ser. Ser. E. 1996, 317).
50. In our studies this also occurred to some extent, since the mutants having a low activity (which in some cases may lead to higher enantioselectivities) are "sorted out" upon screening. Only those mutants are considered which induce a notable conversion within ten minutes under the reaction conditions. Indeed, many mutants show practically no activity, which is not surprising.
51. L. E. Janes, R. J. Kazlauskas, J. Org. Chem. 1997, 62, 4560-4561.